GNA14 may be a potential prognostic biomarker in nasopharyngeal carcinoma

BackgroundNasopharyngeal carcinoma (NPC) is a highly invasive malignant tumor. Recurrence and distant metastasis represent the primary causes of treatment failure. This study aimed to identify biomarkers highly associated with NPC and investigate its roles in tumor progression.MethodsTranscriptome s...

Full description

Saved in:
Bibliographic Details
Main Authors: Jinrong Hao, Xia Yu, Lei Xiong, Li Deng, Shifeng Lian, Shijun Sun, Xiaoling Li, Yun Du, Mingfang Ji
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1482038/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846156383429328896
author Jinrong Hao
Xia Yu
Lei Xiong
Li Deng
Shifeng Lian
Shijun Sun
Xiaoling Li
Yun Du
Mingfang Ji
author_facet Jinrong Hao
Xia Yu
Lei Xiong
Li Deng
Shifeng Lian
Shijun Sun
Xiaoling Li
Yun Du
Mingfang Ji
author_sort Jinrong Hao
collection DOAJ
description BackgroundNasopharyngeal carcinoma (NPC) is a highly invasive malignant tumor. Recurrence and distant metastasis represent the primary causes of treatment failure. This study aimed to identify biomarkers highly associated with NPC and investigate its roles in tumor progression.MethodsTranscriptome sequencing (RNA-seq) data of NPC and normal tissues were downloaded from the Gene Expression Omnibus (GEO) database. By analyzing the RNA-seq data, we found that G Protein Subunit Alpha 14 (GNA14) is closely associated with the diagnosis and prognosis of NPC. Immunohistochemistry (IHC) was used to detect the expression of GNA14 in tumor tissues of 165 NPC patients, and we analyzed the relationship between GNA14 expression and patient prognosis. The potential mechanisms by which GNA14 affects tumor prognosis were preliminarily analyzed using bioinformatics analysis.ResultsAnalysis of RNA-seq data and IHC showed that GNA14 expression was downregulated in NPC (p < 0.001, p < 0.01, respectively), and low expression of GNA14 was closely associated with poor prognosis. IHC analysis showed that patients with low GNA14 expression had significantly shorter progression-free survival (PFS) and distant metastasis-free survival (DMFS) than those with high GNA14 expression (p = 0.023, p = 0.008, respectively). Multivariate analysis indicated that the GNA14 expression was an independent risk factor for DMFS (p = 0.030). The DMFS nomogram included GNA14 expression, EBV DNA, and N stage as prognostic factors and the concordance index (C-index) of the nomogram was 0.73. Bioinformatics analysis indicated that NPC patients with low GNA14 expression might represent lower levels of immune cell infiltration and poorer drug sensitivity.ConclusionLow GNA14 expression may be a risk factor for poor prognosis in NPC.
format Article
id doaj-art-58c210ee2c714f46be4246ecbb4e9d27
institution Kabale University
issn 2234-943X
language English
publishDate 2024-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-58c210ee2c714f46be4246ecbb4e9d272024-11-26T06:26:12ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-11-011410.3389/fonc.2024.14820381482038GNA14 may be a potential prognostic biomarker in nasopharyngeal carcinomaJinrong Hao0Xia Yu1Lei Xiong2Li Deng3Shifeng Lian4Shijun Sun5Xiaoling Li6Yun Du7Mingfang Ji8Cancer Research Institute of Zhongshan City, Zhongshan City People’s Hospital, Zhongshan, ChinaCancer Research Institute of Zhongshan City, Zhongshan City People’s Hospital, Zhongshan, ChinaCancer Research Institute of Zhongshan City, Zhongshan City People’s Hospital, Zhongshan, ChinaCancer Research Institute of Zhongshan City, Zhongshan City People’s Hospital, Zhongshan, ChinaCancer Research Institute of Zhongshan City, Zhongshan City People’s Hospital, Zhongshan, ChinaDepartment of Pathology, Zhongshan City People’s Hospital, Zhongshan, ChinaCancer Research Institute of Zhongshan City, Zhongshan City People’s Hospital, Zhongshan, ChinaDepartment of Oncology, Southwest Hospital, Army Medical University, Chongqing, ChinaCancer Research Institute of Zhongshan City, Zhongshan City People’s Hospital, Zhongshan, ChinaBackgroundNasopharyngeal carcinoma (NPC) is a highly invasive malignant tumor. Recurrence and distant metastasis represent the primary causes of treatment failure. This study aimed to identify biomarkers highly associated with NPC and investigate its roles in tumor progression.MethodsTranscriptome sequencing (RNA-seq) data of NPC and normal tissues were downloaded from the Gene Expression Omnibus (GEO) database. By analyzing the RNA-seq data, we found that G Protein Subunit Alpha 14 (GNA14) is closely associated with the diagnosis and prognosis of NPC. Immunohistochemistry (IHC) was used to detect the expression of GNA14 in tumor tissues of 165 NPC patients, and we analyzed the relationship between GNA14 expression and patient prognosis. The potential mechanisms by which GNA14 affects tumor prognosis were preliminarily analyzed using bioinformatics analysis.ResultsAnalysis of RNA-seq data and IHC showed that GNA14 expression was downregulated in NPC (p < 0.001, p < 0.01, respectively), and low expression of GNA14 was closely associated with poor prognosis. IHC analysis showed that patients with low GNA14 expression had significantly shorter progression-free survival (PFS) and distant metastasis-free survival (DMFS) than those with high GNA14 expression (p = 0.023, p = 0.008, respectively). Multivariate analysis indicated that the GNA14 expression was an independent risk factor for DMFS (p = 0.030). The DMFS nomogram included GNA14 expression, EBV DNA, and N stage as prognostic factors and the concordance index (C-index) of the nomogram was 0.73. Bioinformatics analysis indicated that NPC patients with low GNA14 expression might represent lower levels of immune cell infiltration and poorer drug sensitivity.ConclusionLow GNA14 expression may be a risk factor for poor prognosis in NPC.https://www.frontiersin.org/articles/10.3389/fonc.2024.1482038/fullnasopharyngeal carcinomabiomarkerGNA14ebvprognosisimmunohistochemistry
spellingShingle Jinrong Hao
Xia Yu
Lei Xiong
Li Deng
Shifeng Lian
Shijun Sun
Xiaoling Li
Yun Du
Mingfang Ji
GNA14 may be a potential prognostic biomarker in nasopharyngeal carcinoma
Frontiers in Oncology
nasopharyngeal carcinoma
biomarker
GNA14
ebv
prognosis
immunohistochemistry
title GNA14 may be a potential prognostic biomarker in nasopharyngeal carcinoma
title_full GNA14 may be a potential prognostic biomarker in nasopharyngeal carcinoma
title_fullStr GNA14 may be a potential prognostic biomarker in nasopharyngeal carcinoma
title_full_unstemmed GNA14 may be a potential prognostic biomarker in nasopharyngeal carcinoma
title_short GNA14 may be a potential prognostic biomarker in nasopharyngeal carcinoma
title_sort gna14 may be a potential prognostic biomarker in nasopharyngeal carcinoma
topic nasopharyngeal carcinoma
biomarker
GNA14
ebv
prognosis
immunohistochemistry
url https://www.frontiersin.org/articles/10.3389/fonc.2024.1482038/full
work_keys_str_mv AT jinronghao gna14maybeapotentialprognosticbiomarkerinnasopharyngealcarcinoma
AT xiayu gna14maybeapotentialprognosticbiomarkerinnasopharyngealcarcinoma
AT leixiong gna14maybeapotentialprognosticbiomarkerinnasopharyngealcarcinoma
AT lideng gna14maybeapotentialprognosticbiomarkerinnasopharyngealcarcinoma
AT shifenglian gna14maybeapotentialprognosticbiomarkerinnasopharyngealcarcinoma
AT shijunsun gna14maybeapotentialprognosticbiomarkerinnasopharyngealcarcinoma
AT xiaolingli gna14maybeapotentialprognosticbiomarkerinnasopharyngealcarcinoma
AT yundu gna14maybeapotentialprognosticbiomarkerinnasopharyngealcarcinoma
AT mingfangji gna14maybeapotentialprognosticbiomarkerinnasopharyngealcarcinoma